Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/86359
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug

AutorVega, María Celeste; Rolón, M.; Montero-Torres, Alina; Fonseca-Berzal, Cristina; Escario, José Antonio; Gómez-Barrio, Alicia; Gálvez, J.; Marrero-Ponce, Yovani; Arán, Vicente J. CSIC ORCID
Fecha de publicación2012
EditorElsevier
CitaciónEuropean Journal of Medicinal Chemistry 58: 214- 227 (2012)
ResumenChagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3- ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22-32, 34-38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22-24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease. © 2012 Elsevier Masson SAS. All rights reserved.
URIhttp://hdl.handle.net/10261/86359
DOI10.1016/j.ejmech.2012.10.009
Identificadoresdoi: 10.1016/j.ejmech.2012.10.009
issn: 0223-5234
e-issn: 1768-3254
Aparece en las colecciones: (IQM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

48
checked on 22-mar-2024

WEB OF SCIENCETM
Citations

48
checked on 24-feb-2024

Page view(s)

374
checked on 27-mar-2024

Download(s)

141
checked on 27-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.